Cogent Biosciences (COGT) Free Cash Flow: 2017-2021
Historic Free Cash Flow for Cogent Biosciences (COGT) over the last 5 years, with Dec 2021 value amounting to -$21.2 million.
- Cogent Biosciences' Free Cash Flow fell 126.46% to -$21.2 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$60.4 million, marking a year-over-year decrease of 68.37%. This contributed to the annual value of -$208.4 million for FY2024, which is 33.21% down from last year.
- According to the latest figures from Q4 2021, Cogent Biosciences' Free Cash Flow is -$21.2 million, which was down 38.88% from -$15.3 million recorded in Q3 2021.
- In the past 5 years, Cogent Biosciences' Free Cash Flow ranged from a high of -$6.0 million in Q2 2017 and a low of -$21.2 million during Q4 2021.
- Moreover, its 3-year median value for Free Cash Flow was -$10.8 million (2019), whereas its average is -$11.5 million.
- Its Free Cash Flow has fluctuated over the past 5 years, first soared by 31.72% in 2020, then plummeted by 126.46% in 2021.
- Cogent Biosciences' Free Cash Flow (Quarterly) stood at -$6.6 million in 2017, then slumped by 36.34% to -$9.0 million in 2018, then grew by 6.23% to -$8.5 million in 2019, then fell by 10.74% to -$9.4 million in 2020, then plummeted by 126.46% to -$21.2 million in 2021.
- Its last three reported values are -$21.2 million in Q4 2021, -$15.3 million for Q3 2021, and -$12.5 million during Q2 2021.